AAD
Author: Willhemenia Loremipsum Special session: Lorem ipsum dolor sit amet Category: Lorem ipsum View all results

Please login or create an account. If you do not have access to this content, you will be shown a 30 second preview and licensing options.

  • Presentation

The Newest Approaches to Scars and Laser Assisted Drug Delivery

Description

Dr. Jill Weibel, a pioneer in laser treatment and drug delivery for scars, presented innovative approaches in the field, highlighting advancements in laser technology and its application in scar management. The introduction of next-generation lasers is anticipated, with fractional lasers viewed as a mainstay for effective treatments. Laser-assisted drug delivery utilizes lasers to create micro-channels in scar tissue, allowing for precise and efficient drug administration, aiming to improve clinical outcomes in scar treatment. Along with traditional therapies, emerging technologies, including nanocarriers and smart drugs, aim to revolutionize drug delivery in dermatology and beyond, potentially streamlining treatment protocols and reducing healthcare costs. Dr. Weibel discussed various scar types and treatment strategies, emphasizing the effective use of laser-assisted delivery for both hypertrophic and atrophic scars. The use of chemotherapeutic agents like triamcinolone, in combination with laser treatments, has shown promising results. Additionally, regenerative medicine approaches are being explored, with successful experiments indicated using laser delivery methods in wound healing and potential applications in conditions like leukemia. Overall, the integration of laser technology in scar treatment showcases a future of improved outcomes and innovative healthcare solutions.

View more

Conclusions

  • Laser-assisted drug delivery (LADD) enhances scar treatment outcomes by creating microchannels that allow deeper penetration of therapeutic agents.
  • Advancements in laser technology, particularly in fractional lasers, improve efficacy in scar treatments.
  • LADD is gaining momentum as a novel approach to efficiently deliver drugs while minimizing systemic side effects.
  • Combination therapies that integrate LADD with traditional treatments provide better management of hypertrophic and atrophic scars.
  • Innovative treatments involving nanocarriers and smart drug formulations may further enhance outcomes in scar management.
  • Clinical evidence supports the use of LADD for various scar types, leading to improved patient satisfaction and clinical results.
  • The use of LADD can potentially lower healthcare costs by reducing the required dosages of therapeutic agents due to increased absorption.
  • Regulatory pathways are evolving to better integrate LADD into standard dermatological practices, indicating a positive trend for future applications.
  • Labadie et al. JAMA Dermatol. 2022 Aug 17.
  • Waibel J, Rudnick A, Shumaker P. Laser Assisted Delivery of Therapeutic Agents. The Scar Book: Formation, Mitigation, Rehabilitation and Prevention. 14:205-211.
  • Waibel, J, Rudnick, A. Laser-Assisted Delivery to Treat Facial Scars. Facial Plastic Surgery Clinics of North America. Volume 25, Issue 1, Pages 105-117.
  • Cheyasak et al 2015 Acta Dermato Venereol 2015: 95(2) 201-205.
  • Elshabory O, Mohamed HAK, Zaky M, Elsaie ML. Arch Dermatol Res. 2025 Jan 13;317(1):241. doi: 10.1007/s00403-024-03715-5.
  • Rkein A1, Ozog D, Waibel JS. Treatment of Atrophic Scars With Fractionated CO2 Laser Facilitating Delivery of Topically Applied Poly-L-lactic Acid. Dermatology Surg. 2014 Jun; 40(6)624-31.
  • Alexis B. Lyons, MD, David M. Ozog, MD, Henry W. Lim, MD, Kate Viola, MD, Amy Tang, PhD, Lamont R. Jones, MD, MBA. The Detroit Keloid Scale: A Validated Tool for Rating Keloids.
  • Meghan Seago, MD, Peter R. Shumaker, MD, Leah K. Spring, Do, Murad Alam, MD, Firas Al-Niaimi, MSc, MRCP, EBDV, R. Rox Anderson, MD, Ofir Artzi, MD, Ardeshir Bayat, BSc (Hons), MBBS, PhD, Henry HL Chan, MD, PhD, Christine Dierickx, MD, Matthias Donelan, MD. 2020 International Consensus Recommendations.
  • Nourian Dehkordi, A., Mirahmadi Babaheydari, F., Chehelgerdi, M. et al. Skin tissue engineering: wound healing based on stem-cell-based therapeutic strategies. Stem Cell Res Ther 10, 111 (2019).
  • Singh AM, Reynolds D, Cliff T, Ohtsuka S, Mattheyses AL, Sun Y, Menendez L, Kulik M, Dalton S. Signaling network crosstalk in human pluripotent cells: a Smad2/3-regulated switch that controls the balance between self-renewal and differentiation. Cell Stem Cell. 2012 Mar 2;10(3):312-26.
  • MILLER SCHOOL OF MEDICINE UNIVERSITY OF MIAMI. Published: March 25, 2014 https://doi.org/10.1371/journal.pone.0093004.